L. Valiquette

F. Saad, F. Montorsi, M. Graefen, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management

M. Emberton, W. Rayford, L. Valiquette, 2005, BJU international.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer

A. Haese*, F. Montorsi, A. Salonia, 2008, BJU international.

Health‐insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer

A. Haese*, F. Montorsi, A. Salonia, 2007, BJU international.

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

F. Saad, F. Montorsi, F. Bénard, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

F. Montorsi, F. Bénard, M. Graefen, 2008, The journal of sexual medicine.

Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2007, Urology.

Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.

U. Capitanio, F. Montorsi, M. Graefen, 2009, Journal of endourology.

Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy.

G. Herbison, L. Valiquette, M. Chetner, 2008, Urology.

Questionnaires to assess urinary and anal incontinence: review and recommendations.

J. Donovan, M. Naughton, L. Valiquette, 2007, The Journal of urology.

Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction - RELY-II.

F. Montorsi, L. Valiquette, S. Auerbach, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study.

F. Montorsi, L. Valiquette, H. Porst, 2005, Mayo Clinic proceedings.

First‐dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY‐I

F. Montorsi, L. Valiquette, S. Auerbach, 2006, International journal of clinical practice.

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.

F. Montorsi, S. Segal, J. Denne, 2004, European urology.

Vardenafil provides reliable efficacy over time in men with erectile dysfunction.

F. Montorsi, W. Hellstrom, I. Eardley, 2004, Urology.

Economic evaluation of NMP22 in the management of bladder cancer.

L. Valiquette, J. Lachaine, R. Crott, 2000, The Canadian journal of urology.

Therapeutic approach to hormone-refractory prostate cancer.

F. Saad, F. Bénard, P. Karakiewicz, 2006, The Canadian journal of urology.

Childhood trauma and dissociation in first-episode psychosis, chronic schizophrenia and community controls

A. Ciampi, A. Malla, R. Joober, 2013, Psychiatry Research.

French-Canadian linguistic validation of the NIH Chronic Prostatitis Symptom Index.

F. Bénard, P. Karakiewicz, L. Valiquette, 2005, The Canadian journal of urology.

Urinary Incontinence

L. Valiquette, J. Couture, 2000, The Annals of pharmacotherapy.

Impact of chronic prostatitis‐like symptoms on the quality of life in a large group of men

F. Bénard, P. Karakiewicz, J. Walz, 2007, BJU international.

Long-term safety experience with tadalafil

F. Montorsi, J. Denne, L. Valiquette, 2003 .

PICA/burden: a staging system for upper tract urinary stones.

L. Valiquette, D. Griffith, Donald P. Griffith, 1987, The Journal of urology.

Staghorn calculi treated by percutaneous nephrolithotomy: risk factors for recurrence.

F. Saad, L. Valiquette, J. Perreault, 1993, Urology.

Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.

F. Saad, U. Capitanio, M. Graefen, 2009, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

QUESTIONS AND ANSWERS AFTER LINDA BRUBAKER, LINDA D. CARDOZO, AND MAGNUS FALL

M. Fall, P. Abrams, L. Cardozo, 2000, Urology.

Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue

R. Godbout, E. Stip, B. Jemel, 2022, Nature Communications.

Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2007, European urology.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

A. Haese*, T. Schlomm, M. Graefen, 2007, European journal of cancer.

Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.

M. Kattan, P. Scardino, H. Heinzer, 2005, The Journal of urology.

Development and external validation of an extended repeat biopsy nomogram.

A. Haese*, F. Montorsi, A. Salonia, 2007, The Journal of urology.

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

C. Roehrborn, A. Haese*, F. Montorsi, 2006, BJU international.

Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2006, European urology.

[Ureteroscopy versus in situ extracorporeal shockwave lithotripsy in the treatment of calculi of the distal ureter].

F. Bénard, L. Valiquette, J. Perreault, 1996, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery.

D. Redelmeier, J. Katz, L. Valiquette, 1999, The Journal of urology.

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

F. Saad, F. Montorsi, F. Bénard, 2007, European journal of cancer.

Accuracy of life tables in predicting overall survival in patients after radical prostatectomy

F. Saad, M. Graefen, S. Shariat, 2008, BJU international.

Development and external validation of an extended 10-core biopsy nomogram.

A. Haese*, F. Montorsi, P. Rigatti, 2007, European urology.

Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.

C. Roehrborn, S. Shariat, P. Karakiewicz, 2008, The Journal of trauma.

Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder.

F Bénard, F. Bénard, L. Valiquette, 1999, The Journal of urology.

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin

C. Roehrborn, F. Montorsi, P. Rigatti, 2007, BJU international.

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer

F. Saad, F. Bénard, A. Briganti, 2007, BJU international.

Update of the ICUD-SIU consultation on stone technology behind ureteroscopy

M. Pearle, O. Traxer, L. Valiquette, 2017, World Journal of Urology.

Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.

Andrea Salonia, Pierre I Karakiewicz, Francesco Montorsi, 2006, European urology.

Concerns regarding sacral neuromodulation as a treatment option for medical-refractory overactive bladder.

D. Liberman, L. Valiquette, 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

J. Gajewski, L. Valiquette, S. Herschorn, 2011, The Journal of urology.

Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.

F. Saad, U. Capitanio, F. Montorsi, 2009, The Journal of urology.

A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer.

F. Montorsi, A. Salonia, P. Rigatti, 2007, European urology.

Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.

F. Montorsi, M. Graefen, L. Budäus, 2010, The Journal of urology.

Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.

F. Saad, F. Montorsi, F. Bénard, 2010, International journal of radiation oncology, biology, physics.

Perceived effects of the 16-hour workday restriction on surgical specialties: Quebec's experience.

G. Fried, J. Latulippe, L. Valiquette, 2014, Journal of surgical education.

Creation and Testing of the Geriatric Self‐Efficacy Index for Urinary Incontinence

C. Tannenbaum, N. Korner-Bitensky, L. Valiquette, 2008, Journal of the American Geriatrics Society.

Canadian Experience with the Adjustable Trans-Obturator Male System (ATOMS) for Post-prostatectomy Incontinence: A Multi-Centered Study.

L. Valiquette, J. Morisset, D. Elterman, 2019, The Journal of urology.

Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

F. Montorsi, F. Bénard, M. Graefen, 2008, Journal of endourology.

Outcomes research: a methodologic review.

A. Briganti, P. Karakiewicz, F. Chun, 2006, European urology.

Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.

F. Saad, M. Elhilali, L. Valiquette, 2005, The Canadian journal of urology.

Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.

F. Bénard, L. Valiquette, A. Duclos, 2000, The Canadian journal of urology.

The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.

Umberto Capitanio, Alain Duclos, Pierre I Karakiewicz, 2010, International journal of radiation oncology, biology, physics.

The Effect of Obesity on Perioperative Outcomes Following Percutaneous Nephrolithotomy.

A. Briganti, S. Shariat, P. Karakiewicz, 2016, Journal of endourology.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

F. Montorsi, A. Salonia, P. Rigatti, 2007, European urology.

A population based assessment of perioperative mortality after cystectomy for bladder cancer.

Michael McCormack, Umberto Capitanio, Alain Duclos, 2009, The Journal of urology.

FPSUND: a new clinical classification of urinary incontinence.

L. Valiquette, A. Duclos, S. Lapointe, 2000, The Canadian journal of urology.

[FPSUND: a pan-Canadian evaluation of a clinical classification of urinary incontinence].

J. Gajewski, L. Valiquette, A. Duclos, 1998, Annales de Chirurgie.

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

F. Montorsi, A. Salonia, P. Rigatti, 2007, European urology.

Expression of CYP27A, a gene encoding a vitamin D‐25 hydroxylase in human liver and kidney

L. Valiquette, Glenville Jones, G. Jones, 2001, Clinical endocrinology.

High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

F. Saad, F. Montorsi, M. Graefen, 2008, European urology.

Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.

F. Saad, F. Bénard, S. Shariat, 2005, The Canadian journal of urology.

Development and internal validation of preoperative transition zone prostate cancer nomogram.

A. Haese*, T. Schlomm, M. Graefen, 2006, Urology.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

L. Valiquette, G. Broderick, D. Hatzichristou, 2006, Journal of Sexual Medicine.

Responsiveness and Clinical Utility of the Geriatric Self‐Efficacy Index for Urinary Incontinence

C. Tannenbaum, N. Korner-Bitensky, L. Valiquette, 2009, Journal of the American Geriatrics Society.

Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.

F. Saad, F. Bénard, M. Graefen, 2007, International Journal of Radiation Oncology, Biology, Physics.

Ejaculatory disorders may affect screening for prostate cancer.

F. Montorsi, F. Bénard, P. Karakiewicz, 2007, The Journal of urology.

Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial.

M. Latour, D. Liberman, L. Valiquette, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.

A. Shalhav, O. Gofrit, P. Karakiewicz, 2007, Journal of endourology.

Prostate specific‐antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer

A. Briganti, P. Karakiewicz, L. Valiquette, 2006, BJU international.

Managing adults with urinary incontinence. Clinical practice guidelines.

M. Borrie, L. Valiquette, 2002, Canadian family physician Medecin de famille canadien.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

L. Valiquette, G. Broderick, D. Hatzichristou, 2006, The journal of sexual medicine.